Open Actively Recruiting

Active Surveillance for Cancer of the Prostate (ASCaP)

About

Brief Summary

Active Surveillance (A.S.) of prostate cancer (CaP) is the systematic monitoring of men with low-risk, localized lesions, with curative treatment of those whose tumors show substantial progression. A.S. is different from Watchful Waiting (W.W.), which is the palliative treatment of men with progressive prostate cancer.

Study Type
Observational
Phase
N/A

Eligibility

Gender
Male
Healthy Volunteers
No
Minimum Age
30 Years
Maximum Age
85 Years

Inclusion Criteria:

  • Histologically confirmed adenocarcinoma of the prostate.
  • Clinically localized prostate cancer: T1-2, NX or N0, MX or M0.
  • No previous treatment for prostate cancer (including hormonal therapy, radiation therapy, surgery, or chemotherapy).
  • Patient has elected Active Surveillance as preferred management plan for prostate cancer.
  • Patient consent has been obtained according to local Institutional Review Board .
  • Patient is accessible and compliant for follow-up.

Exclusion Criteria:

  • Unwillingness or inability to undergo serial prostate biopsy.
  • Overall life expectancy less than 2 years
  • Advanced prostate cancer

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
11-002281
Category
Oncology
Urology
Contact
Merdie Delfin
Location
  • UCLA Westwood
For Providers
NCT No.
NCT00949819
For detailed technical eligibility, visit ClinicalTrials.gov.